Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENCO Analytix is a biotechnology company specializing in advanced molecular diagnostics and the development of normalization technologies for genomic and proteomic data. The company's core technology, the ENCO (Endogenous Control) platform, identifies and utilizes stable endogenous biological markers to ensure the accuracy and reproducibility of liquid biopsy and tissue-based assays. By providing a sophisticated framework for data normalization, ENCO Analytix enables more precise detection of disease-specific signals and improved monitoring of therapeutic responses in oncology. Operating as a specialized entity within the Caris Life Sciences ecosystem, the company integrates its analytical tools into comprehensive molecular profiling services to advance precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ENCO Analytix.